Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Iovance Biotherapeutics Inc
(NQ:
IOVA
)
11.87
+0.25 (+2.15%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Iovance Biotherapeutics Inc
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Tesla, Nokia And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
October 19, 2023
U.S. stock futures traded lower this morning on Thursday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Iovance Biotherapeutics Announces Clinical Data for Lifileucel in Advanced Mucosal Melanoma at the European Society for Medical Oncology (ESMO) Congress
October 16, 2023
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race
October 10, 2023
Large pharmaceutical companies are increasingly investing in cancer treatment stocks, driven by the promise of medical breakthroughs and financial rewards. Eli Lilly became the latest Big Pharma giant...
Via
PressReach
Why Shares of Iovance Biotherapeutics Jumped Monday
September 18, 2023
The company's stock rally began on Friday.
Via
The Motley Fool
Where Iovance Biotherapeutics Stands With Analysts
September 13, 2023
Via
Benzinga
Iovance Biotherapeutics to Present Clinical and Pre-Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapies at Society for Tumor Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
September 27, 2023
Four-year Analysis of C-144-01 Trial Cohorts 2 and 4
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
September 22, 2023
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
10 Health Care Stocks Whale Activity In Today's Session
September 18, 2023
Via
Benzinga
Expert Ratings for Iovance Biotherapeutics
August 09, 2023
Via
Benzinga
Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
September 18, 2023
Gainers
Via
Benzinga
Over $26M Bet On This Biotechnology Stock? Check Out These 4 Stocks Insiders Are Buying
September 18, 2023
Although U.S. stocks closed lower on Friday, there were a few notable insider trades.
Via
Benzinga
Alteryx, Iovance Biotherapeutics And Other Big Stocks Moving Higher In Monday's Pre-Market Session
September 18, 2023
U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording gains in today’s pre-market trading session. Newegg Commerce, Inc. (NASDAQ: NEGG) shares climbed 8.7% to...
Via
Benzinga
Why Iovance Biotherapeutics Stock Rocketed 13% Higher Today
September 15, 2023
The approval process for the biotech's most advanced pipeline drug program is going quite well, it seems.
Via
The Motley Fool
Personalized Skin Cancer Therapy, Despite FDA Delay: Analysts Show Confidence In Iovance Biotherapeutics Therapy
September 15, 2023
Thursday, the FDA extended the review period for Iovance Biotherapeutics Inc's (NASDAQ: IOVA) marketing application seeking accelerated approval for lifileucel
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Friday's Intraday Session
September 15, 2023
Via
Benzinga
Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day Session
September 15, 2023
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 127.8% to $0.1269. The company recently reported second-quarter results.
Via
Benzinga
Nasdaq Down Over 1%; US Industrial Output Rises In August
September 15, 2023
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% points on Friday. The Dow traded down 0.52% to 34,727.05 while the NASDAQ fell 1.31% to 13,743.78. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Iovance Biotherapeutics Inc. (NASDAQ: IOVA) is One of Friday Morning’s Most Active Stocks
September 15, 2023
Via
Investor Brand Network
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 15, 2023
Via
Benzinga
Why Volcon Shares Are Trading Lower By 19%; Here Are 20 Stocks Moving Premarket
September 15, 2023
Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares rose 38.7% to $0.1421 in pre-market trading after gaining 10% on Thursday.
Via
Benzinga
Mitek Systems, Arm Holdings And Other Big Stocks Moving Higher In Friday's Pre-Market Session
September 15, 2023
U.S. stock futures traded mostly higher this morning on Friday. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
U.S. Food and Drug Administration Updates Prescription Drug User Fee Act (PDUFA) Action Date for Lifileucel for the Treatment of Advanced Melanoma
September 14, 2023
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Why Shares of Iovance Biotherapeutics Dropped Thursday
September 14, 2023
The biotech stock's lead therapy is looking at some competition.
Via
The Motley Fool
Why Clearmind Medicine Shares Are Trading Lower By 53%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
September 14, 2023
Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares jumped 89.5% to $0.8243 after the company announced license agreement for capeserod from Sanofi.
Via
Benzinga
Iovance Biotherapeutics Stock Is Down 15%: What's Going On?
September 14, 2023
Iovance Biotherapeutics Inc (NASDAQ: IOVA) shares are trading lower by 15.8% to $4.58, despite a lack of company-specific news for the session.
Via
Benzinga
Iovance Biotherapeutics to Present at 2023 Wells Fargo Healthcare Conference
September 07, 2023
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
3 Up-and-Coming Biotech Stocks to Put on Your Must-Buy List
August 28, 2023
Here are some intriguing up-and-coming biotech stocks that may reward risk-tolerant investors with a long-term outlook.
Via
InvestorPlace
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
August 18, 2023
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Iovance Biotherapeutics Reports Second Quarter and First Half 2023 Financial Results and Corporate Updates
August 08, 2023
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Cathie Wood Continues Iridium Shopping Spree — Ark Invest Buys $3.6M Worth Of Satellite Company's Stock
August 02, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.